Plant Sterols and Stanols in the Treatment of Dyslipidemia: New Insights into Targets and Mechanisms Related to Cardiovascular Risk

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|17|9|922-932

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.17, Iss.9, 2011-03, pp. : 922-932

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Plant sterols and stanols in hypercholesterolaemia

By  

Inpharma, Vol. 1, Iss. 1405, 2003-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Editorial (Thematic Issue: Novel Data on the Pathogenesis of Atherosclerosis, Treatment Targets, and New Therapeutic Interventions in Lipid-Related Cardiovascular Risk Factors)

By  

Current Pharmaceutical Design, Vol. 20, Iss. 40, 2014-12 ,pp. : 6215-6219

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging Targets for the Treatment of Dyslipidemia

By  

Current Medicinal Chemistry, Vol. 18, Iss. 6, 2011-02 ,pp. : 909-922

Bentham Science Publishers

Access to resources Recommend Favorite

A Review on the Role of Phytosterols: New Insights Into Cardiovascular Risk

By  

Current Pharmaceutical Design, Vol. 17, Iss. 36, 2011-12 ,pp. : 4061-4075

Bentham Science Publishers

Access to resources Recommend Favorite

Risk of Bleeding Related to Antithrombotic Treatment in Cardiovascular Disease

By  

Current Pharmaceutical Design, Vol. 18, Iss. 33, 2012-11 ,pp. : 5362-5378

Bentham Science Publishers

Access to resources Recommend Favorite